missing translation for 'onlineSavingsMsg'
Learn More

CDK1/2/3 [p Thr14] Antibody, Novus Biologicals™

Rabbit Monoclonal Antibody

213.00€ - 507.00€

Specifications

Antigen CDK1/2/3
Dilution Western Blot 1:500 - 1:1000, ELISA Recommended starting concentration is 1 μg/mL
Applications ELISA, Western Blot
Classification Monoclonal
Conjugate Unconjugated
View More Specs

Products 2
Product Code Brand Quantity Price Quantity & Availability  
Product Code Brand Quantity Price Quantity & Availability  
30228276
View Documents
Novus Biologicals
NBP3-33561-100ul
100 μL
507.00€
100µL
View alternative products
Save Up to 
»
Please to purchase this item. Need a web account? Register with us today!
30227769
View Documents
Novus Biologicals
NBP3-33561-20ul
20 μL
213.00€
20µL
View alternative products
Save Up to 
»
Please to purchase this item. Need a web account? Register with us today!
Description

Description

CDK1/2/3 Monoclonal antibody specifically detects CDK1/2/3 in Human,Mouse,Rat samples. It is validated for ELISA,Western Blot
Specifications

Specifications

CDK1/2/3
ELISA, Western Blot
Unconjugated
Rabbit
Human, Mouse, Rat
A synthetic phosphorylated peptide around T14 of human CDK1/2/3 (P06493).,, Sequence:, EGTYG
Primary
Store at -20°C. Avoid freeze-thaw cycles.
Western Blot 1:500 - 1:1000, ELISA Recommended starting concentration is 1 μg/mL
Monoclonal
Purified
RUO
PBS (pH 7.3), 50% glycerol, 0.05% BSA
IgG
Affinity purified
Videos
SDS
Documents

Documents

Product Certifications
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.